- Proteostasis Therapeutics (NASDAQ:PTI) -37% on mixed results in mid-stage CF study.
- More news on: Proteostasis Therapeutics, Inc., MEI Pharma, Inc., VistaGen Therapeutics, Inc., Stocks on the move, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Unilever’s Personal Care brands – Axe, Degree, Dove, and Dove Men+Care – named Official Sponsors of CONMEBOL Copa América USA 2024™ This marks the first time Unilever has sponsored the tournament. A range of sponsorship activations and one-of-a-kind experi...
Company selected by U.S. Department of Energy for award negotiations Unilever today announced that a major project to significantly reduce carbon emissions at its Ice Cream Business Group’s four U.S. factories has been selected by the U.S. Department of Energy for award negotiati...
Unilever United States Inc. is voluntarily recalling select Knorr Sopa Soup Mix products because the products may contain egg, which is not listed as an ingredient on the label. Persons who have an allergy or severe sensitivity to egg run the risk of a serious or life-threatening allergic reactio...